Cleared Special

K112082 - GUIDELINER V2 CATHETER

K112082 is the FDA 510(k) clearance for GUIDELINER V2 CATHETER by Vascular Solutions, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 133-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
133d
Days
Class 2
Risk

K112082 is an FDA 510(k) clearance for the GUIDELINER V2 CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vascular Solutions, Inc. (Minneapolis, US). The FDA issued a Cleared decision on December 1, 2011 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Vascular Solutions, Inc. devices

Submission Details

510(k) Number K112082 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2011
Decision Date December 01, 2011
Days to Decision 133 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 519
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K112082.
M2 NAVIGATION CATHETER AND GUIDELINER NAVIGATION CATHETER
K112100 · Vascular Solutions, Inc. · Mar 2012
ENVOY DISTAL ACCESS GUIDING CATHETER
K120229 · Codman & Shurtleff, Inc. · Feb 2012
VALET MICRO CATHETER
K112035 · Volcano Corporation · Jan 2012
CLEARWAY RX NB CATHETER
K113112 · Atrium Medical Corp. · Nov 2011
RUBICON SUPPORT CATHETER
K112303 · Boston Scientific · Nov 2011
ATTAIN LDS 6216A LEFT HEART DELIVERY SYSTEM, ATTAIN ACCESS 6218A LEFT HEART DELIVERY SYSTEM, ATTAIN 6216A AND 6218A GUID
K112917 · Medtronic, Inc. · Oct 2011